Back Pain News and Research

Latest Back Pain News and Research

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene International Sàrl today announced that results from a study evaluating the combination of REVLIMID (lenalidomide) plus VIDAZA (azacitidine) in patients 60 years or older with untreated acute myeloid leukemia (AML) were presented at the American Society of Hematology annual meeting in Atlanta, GA.

11 Dec 2012

Spine Revitalizer develops infographic about non-surgical back pain treatment

More than 3 in 4 Americans experience back pain at some point in their life. Thankfully, Spine Revitalizer has released a helpful resource to give basic information for those suffering from back pain.

6 Dec 2012

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

AstraZeneca today announced the presentation of important new data from studies of FASLODEX (fulvestrant) Injection at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium taking place from 4-8 December at the Henry B. Gonzalez Convention Center, San Antonio, Texas.

5 Dec 2012

Study identifies factors that can predict postpartum pelvic girdle pain in working women

A new study of working women has identified factors during pregnancy and postpartum that can predict pain in the joints that comprise the pelvic girdle. While 90 percent of working women in the Netherlands return to work after the birth of their first child, health issues during the postpartum period often require sick leave. Chief among these health issues is pelvic girdle pain (PGP).

5 Dec 2012

Epidural steroid injections for back pain increase risk of bone loss in postmenopausal women

Postmenopausal women suffered significant bone density loss in their hip after they were treated with an epidural steroid injection for back pain relief, according to a Henry Ford Hospital study

1 Dec 2012

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Turkey raises and releases thousands of non-native guineafowl to eat ticks that carry the deadly Crimean-Congo hemorrhagic fever virus. Yet research suggests guineafowl eat few ticks, but carry the parasites on their feathers, possibly spreading the disease they were meant to stop, says a Turkish biologist working at the University of Utah.

30 Nov 2012

Yoga appears to be effective treatment for neck pain

According to published estimates, some 20 percent of the population suffers from chronic neck pain caused by a variety of structural dysfunctions in the neck, resulting in impaired quality of life and lost work time. A German study published in The Journal of Pain showed that yoga appears to be an effective treatment for neck pain and provides added benefits of improved psychological well being and quality of life.

28 Nov 2012

Prevalence of mental health diagnoses increases with long duration of opioid use

Most patients taking opioids for low back pain or other pain syndromes are prescribed low-to moderate doses, but a substantial number are given higher doses. Although there is no consensus on an absolute limit because tolerance varies over time among individual patients, what is known, however, is higher does are associated with elevated risks for side effects, addiction, overdoses and death.

28 Nov 2012

Leading urologic oncologist explains bladder cancer basics

An unhappy bladder won't be ignored. Frequent urination, pain while urinating, burning while urinating, blood in the urine, and even back pain or pelvic pain can all be symptoms of bladder cancer or other urinary tract problems. The trick, however, is that the absence of urinary symptoms doesn't guarantee a healthy bladder.

27 Nov 2012

Modified breast reduction technique noninferior to traditional

Modifying the inferior pedicle technique of breast reduction results in outcomes that are at least comparable to, and perhaps better than, those previously reported, researchers say.

22 Nov 2012

A closer look into the meningitis outbreak's unwitting enablers

Randall Kinnard's legal clients had steroids injected into their backs last summer for a wide range of reasons. ... Now the 25 -- or their survivors -- have engaged Mr. Kinnaird, one of Nashville's leading lawyers, to sue the New England Compounding Center.

20 Nov 2012

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.

19 Nov 2012

Multimodal approach relieves obstetric back and pelvic pain

Pregnant women with low-back pain and pelvic pain could benefit from a multimodal approach of musculoskeletal and obstetric management, say researchers.

13 Nov 2012

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Santarus, Inc. and Pharming Group NV today announced that their pivotal Phase III clinical study to evaluate the safety and efficacy of the investigational drug RUCONEST (recombinant human C1 esterase inhibitor) 50 U/kg for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema (HAE) met the primary endpoint of time to beginning of symptom relief.

7 Nov 2012

Mass. adopts stricter rules, penalties for compounding pharmacies

The emergency regulations will allow the state to monitor contamination and the volume of medicines being made.

3 Nov 2012

ACP urges use of performance measures targeting 'low-value services' to reduce overuse, misuse of these approaches

The American College of Physicians released a position paper Monday pressing for "valid, evidence-based measures" as a means of raising physician awareness and changing clinician behavior.

31 Oct 2012

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.

29 Oct 2012

$Epidural steroid injection may increase risk of bone fractures$

Epidural steroid injection may increase risk of bone fractures

Patients treated with an epidural steroid injection for back pain relief are at increased risk of bone fractures in the spine, according to a Henry Ford Hospital study.

26 Oct 2012

DSM extends license to supply CarboSil® TSPCU for use in AxioMed Spine Corporation’s Freedom® Spinal Discs

DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed’s Freedom® Lumbar and Freedom® Cervical Discs.

24 Oct 2012

Neurophysiologic mechanism may underpin manual therapy effects

Non-thrust manual therapy may reduce chronic low-back pain by attenuating side-to-side differences in the stretch reflex amplitude of the erector spinae muscles, study findings suggest.

24 Oct 2012

Back Pain News and Research

Latest Back Pain News and Research

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Spine Revitalizer develops infographic about non-surgical back pain treatment

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

Study identifies factors that can predict postpartum pelvic girdle pain in working women

Epidural steroid injections for back pain increase risk of bone loss in postmenopausal women

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Yoga appears to be effective treatment for neck pain

Prevalence of mental health diagnoses increases with long duration of opioid use

Leading urologic oncologist explains bladder cancer basics

Modified breast reduction technique noninferior to traditional

A closer look into the meningitis outbreak's unwitting enablers

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Multimodal approach relieves obstetric back and pelvic pain

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Mass. adopts stricter rules, penalties for compounding pharmacies

ACP urges use of performance measures targeting 'low-value services' to reduce overuse, misuse of these approaches

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Epidural steroid injection may increase risk of bone fractures

DSM extends license to supply CarboSil® TSPCU for use in AxioMed Spine Corporation’s Freedom® Spinal Discs

Neurophysiologic mechanism may underpin manual therapy effects

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in